BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14630808)

  • 21. Biclonal chronic lymphocytic leukemia.
    Hsi ED; Hoeltge G; Tubbs RR
    Am J Clin Pathol; 2000 Jun; 113(6):798-804. PubMed ID: 10874880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.
    Lanasa MC; Allgood SD; Slager SL; Dave SS; Love C; Marti GE; Kay NE; Hanson CA; Rabe KG; Achenbach SJ; Goldin LR; Camp NJ; Goodman BK; Vachon CM; Spector LG; Rassenti LZ; Leis JF; Gockerman JP; Strom SS; Call TG; Glenn M; Cerhan JR; Levesque MC; Weinberg JB; Caporaso NE
    Leukemia; 2011 Sep; 25(9):1459-66. PubMed ID: 21617698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin V gene expression in CD5 B-cell malignancies.
    Kipps TJ; Rassenti LZ; Duffy S; Johnson T; Kobayashi R; Carson DA
    Ann N Y Acad Sci; 1992 May; 651():373-83. PubMed ID: 1376056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire.
    Potter KN; Orchard J; Critchley E; Mockridge CI; Jose A; Stevenson FK
    Blood; 2003 Apr; 101(8):3082-4. PubMed ID: 12480699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic density.
    D'Arena G; Dell'Olio M; Musto P; Cascavilla N; Perla G; Savino L; Greco MM
    Leuk Lymphoma; 2001 Aug; 42(4):649-54. PubMed ID: 11697493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal B-cell lymphocytosis.
    Maitre E; Troussard X
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):229-238. PubMed ID: 31585623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
    Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
    Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL).
    Shokri F; Mageed RA; Richardson P; Jefferis R
    Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
    Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
    Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
    Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
    Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.
    Dagklis A; Fazi C; Sala C; Cantarelli V; Scielzo C; Massacane R; Toniolo D; Caligaris-Cappio F; Stamatopoulos K; Ghia P
    Blood; 2009 Jul; 114(1):26-32. PubMed ID: 19029437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
    Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
    Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
    Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
    Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia.
    Ivancević TD; Kurtović NK; Knezević V; Bogdanović A; Mihaljević B; Bozić B; Gotić M
    Srp Arh Celok Lek; 2014; 142(3-4):197-203. PubMed ID: 24839775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients.
    Ohtsubo K; Sata M; Kawaguchi T; Morishige S; Takata Y; Oku E; Imamura R; Seki R; Hashiguchi M; Osaki K; Yakushiji K; Kanaji T; Yoshimoto K; Ueno T; Okamura T
    Int J Hematol; 2009 May; 89(4):452-459. PubMed ID: 19353237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
    Rassenti LZ; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic lymphocytic leukemia with low lymphocyte count.
    Batata A; Shen B
    Cancer; 1993 May; 71(9):2732-8. PubMed ID: 7682147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.